glp 1 vs glp 1/gip Design of a novel long-acting dual GLP-1/GIP receptor agonist The pleiotropic effects of GLP-1

Blockade of IL-10 with a neutralizing antibody fully inhibited exenatide-induced -endorphin expression both in vitro and in vivo, effectively abolishing its mechanical antiallodynic effects in neuropathic rats [63]

Long acting agonists appear to penetrate permeable areas of the blood-brain barrier and act directly on neurons with GLP-1R in the paraventricular nucleus (PVN) and Area Postrema (56, 102, 105)

M.PetrovicN.MittagJ.et al

Supplements are biologically active and can alter treatment outcomes

Take one half teaspoon (1 gram) daily, or as directed by your healthcare practitioner

If the intervals exceed twice the drug half-life, it is recommended to reapply the desensitization protocol